Amy Goundry/LinkedIn
Feb 18, 2026, 12:34
Amy Goundry: Which Are The Next Major Advances in Blood and Plasma-Driven Immune Regulation?
Amy Goundry, Managing Editor at Sage, shared on LinkedIn:
”The blood–immune interface is a dynamic space where cellular and plasma components regulate immune responses across infection, inflammation, and systemic disease.
At Blood and Plasma we’re particularly interested in rigorous mechanistic research in this area, and we’ve just opened a Special Collection on it.
Which area of immune regulation by blood or plasma components will drive the next major advances?
- Cellular crosstalk – How interactions among erythrocytes, platelets, leukocytes, and endothelium regulate immune activation and resolution
- Plasma-mediated immune modulation – How complement, antibodies, cytokines, metabolites, and extracellular vesicles shape immune cell phenotype and function
- Early biomarkers of dysregulation – Identifying markers that detect immune imbalance early and improve risk stratification and therapeutic targeting
- Inflammation–coagulation links – How immune activation and coagulation pathways intersect in thrombosis, sepsis, and systemic inflammatory disease
Vote — and share what trends you’re seeing in your field!”

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 22, 2026, 15:53Howard Smith: Publix’s GreenWise Organic Frozen Berries Have E. coli Contamination
-
Aug 22, 2026, 15:13Arthur Allen: Empowering Clinicians to Act
-
Aug 22, 2026, 15:11Bassem M. Mohammed: Factor VIII Structure Analysis Makes the Cover of the Journal of Thrombosis and Haemostasis
-
Aug 22, 2026, 15:03Ahmed Reda: Your Red Blood Cell Can Tell a Story – Not All Anemia Looks the Same
-
Aug 22, 2026, 14:50Marco Meloni: Clinical Management of the Diabetic Foot Attack
-
Aug 22, 2026, 14:41Nico Gagelmann: What is the Future for Patients with Myeloproliferative Neoplasms?
-
Aug 22, 2026, 14:36Arun V J: Leadership Is a Practice, Not a Position – TRAM Masterclass with Judith Chapman
-
Aug 22, 2026, 13:38Jerome Hadjadj: A New Approach to Refractory Immune Thrombocytopenia
-
Aug 22, 2026, 13:25Christopher Robinson: Hematologic Response to Iron Therapy and Stillbirth Risk